BDSX logo

Biodesix (BDSX) Cash From Operations

Annual CFO

-$22.87 M
+$22.10 M+49.15%

31 December 2023

BDSX Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

-$10.67 M
+$7.90 M+42.54%

30 September 2024

BDSX Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

-$56.84 M
-$6.83 M-13.67%

30 September 2024

BDSX TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BDSX Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+49.1%-178.0%-152.2%
3 y3 years-7.0%-37.0%-112.2%
5 y5 years-29.4%--

BDSX Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-7.0%+49.1%-1238.8%+42.5%-152.2%at low
5 y5 years-29.4%+49.1%-1079.0%+42.5%-1152.7%at low
alltimeall time-29.4%+49.1%-1079.0%+42.5%-1152.7%at low

Biodesix Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$10.67 M(-42.5%)
-$56.84 M(+13.7%)
June 2024
-
-$18.57 M(+21.3%)
-$50.00 M(+64.0%)
Mar 2024
-
-$15.31 M(+24.7%)
-$30.50 M(+33.3%)
Dec 2023
-$22.87 M(-49.1%)
-$12.28 M(+220.0%)
-$22.87 M(+1.5%)
Sept 2023
-
-$3.84 M(-509.6%)
-$22.54 M(-22.4%)
June 2023
-
$937.00 K(-112.2%)
-$29.03 M(-26.6%)
Mar 2023
-
-$7.69 M(-35.7%)
-$39.56 M(-12.0%)
Dec 2022
-$44.97 M
-$11.95 M(+15.7%)
-$44.97 M(+4.1%)
Sept 2022
-
-$10.33 M(+7.7%)
-$43.22 M(+6.2%)
June 2022
-
-$9.59 M(-26.8%)
-$40.68 M(+35.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$13.10 M(+28.5%)
-$30.00 M(+6.3%)
Dec 2021
-$28.22 M(+32.1%)
-$10.20 M(+30.9%)
-$28.22 M(+5.4%)
Sept 2021
-
-$7.79 M(-814.7%)
-$26.78 M(+17.7%)
June 2021
-
$1.09 M(-109.6%)
-$22.76 M(-19.2%)
Mar 2021
-
-$11.33 M(+29.4%)
-$28.16 M(+31.8%)
Dec 2020
-$21.37 M(-1.7%)
-$8.76 M(+132.3%)
-$21.37 M(+69.4%)
Sept 2020
-
-$3.77 M(-12.4%)
-$12.61 M(+42.6%)
June 2020
-
-$4.30 M(-5.2%)
-$8.84 M(+94.8%)
Mar 2020
-
-$4.54 M
-$4.54 M
Dec 2019
-$21.73 M(+22.9%)
-
-
Dec 2018
-$17.68 M
-
-

FAQ

  • What is Biodesix annual cash flow from operations?
  • What is the all time high annual CFO for Biodesix?
  • What is Biodesix annual CFO year-on-year change?
  • What is Biodesix quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Biodesix?
  • What is Biodesix quarterly CFO year-on-year change?
  • What is Biodesix TTM cash flow from operations?
  • What is the all time high TTM CFO for Biodesix?
  • What is Biodesix TTM CFO year-on-year change?

What is Biodesix annual cash flow from operations?

The current annual CFO of BDSX is -$22.87 M

What is the all time high annual CFO for Biodesix?

Biodesix all-time high annual cash flow from operations is -$17.68 M

What is Biodesix annual CFO year-on-year change?

Over the past year, BDSX annual cash flow from operations has changed by +$22.10 M (+49.15%)

What is Biodesix quarterly cash flow from operations?

The current quarterly CFO of BDSX is -$10.67 M

What is the all time high quarterly CFO for Biodesix?

Biodesix all-time high quarterly cash flow from operations is $1.09 M

What is Biodesix quarterly CFO year-on-year change?

Over the past year, BDSX quarterly cash flow from operations has changed by -$6.83 M (-178.04%)

What is Biodesix TTM cash flow from operations?

The current TTM CFO of BDSX is -$56.84 M

What is the all time high TTM CFO for Biodesix?

Biodesix all-time high TTM cash flow from operations is -$4.54 M

What is Biodesix TTM CFO year-on-year change?

Over the past year, BDSX TTM cash flow from operations has changed by -$34.30 M (-152.21%)